Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Kobayashi Pharmaceutical Co Ltd (4967)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5,380.0 -40.0    -0.74%
02/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3301100008 
  • Volume: 1,291,600
  • Bid/Ask: 5,380.0 / 5,393.0
  • Day's Range: 5,301.0 - 5,405.0
Kobayashi Pharmaceutical 5,380.0 -40.0 -0.74%

4967 Balance Sheet

 
Featured here, the Balance Sheet for Kobayashi Pharmaceutical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 158331 171328 168618 161637
Cash and Short Term Investments 79836 95480 99484 101286
Cash - - - -
Cash & Equivalents 71536 87180 91184 92986
Short Term Investments 8300 8300 8300 8300
Total Receivables, Net 52984 44561 37876 34409
Accounts Receivables - Trade, Net 52984 44561 37876 34409
Total Inventory 22081 28441 27822 23177
Prepaid Expenses - - - -
Other Current Assets, Total 3430 2846 3436 2765
Total Assets 267473 270937 266573 252903
Property/Plant/Equipment, Total - Net 47665 45175 43130 41075
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 9655 7204 7258 6938
Intangibles, Net 11959 6174 6176 6181
Long Term Investments 36083 37778 38240 34172
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1 2 2 2
Other Assets, Total -15394 -1698 4831 2731
Total Current Liabilities 56111 47522 48937 48142
Accounts Payable 17305 19569 20288 18573
Payable/Accrued - - - -
Accrued Expenses 2705 1437 2482 3692
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 379 343 343 328
Other Current liabilities, Total 35722 26173 25824 25549
Total Liabilities 62657 56326 57983 54095
Total Long Term Debt 608 533 539 551
Long Term Debt - - - -
Capital Lease Obligations 608 533 539 551
Deferred Income Tax 2594 3046 3280 1123
Minority Interest - 1 1 -
Other Liabilities, Total 3344 5224 5226 4279
Total Equity 204816 214611 208590 198808
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 3450 3450 3450 3450
Additional Paid-In Capital 522 522 522 522
Retained Earnings (Accumulated Deficit) 205681 201746 197386 193129
Treasury Stock - Common -24766 -13671 -13671 -13671
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 19929 22564 20903 15378
Total Liabilities & Shareholders' Equity 267473 270937 266573 252903
Total Common Shares Outstanding 75.04 76.13 76.13 76.13
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4967 Comments

Write your thoughts about Kobayashi Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email